ASP8497
ASP8497 is a competitive dipeptidyl peptidase IV (DPP-IV) inhibitor that reduces blood glucose levels and increases plasma active GLP-1 and insulin levels without causing hypoglycemia in fasted normal mice. ASP8497 can be utilized for antihyperglycemic research[1].
Product Specifications
CAS Number
651055-26-4
UNSPSC
12352005
Target
Dipeptidyl Peptidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/asp8497.html
Smiles
CC1(NCC(N2C[C@@H](F)C[C@H]2C#N)=O)CCN(S(=O)(C)=O)CC1.O=C(O)/C=C/C(O)=O
Molecular Formula
C18H27FN4O7S
Molecular Weight
462.49
References & Citations
[1]Someya Y, et al. Pharmacological profile of ASP8497, a novel, selective, and competitive dipeptidyl peptidase-IV inhibitor, in vitro and in vivo. Naunyn Schmiedebergs Arch Pharmacol. 2008 May;377 (3) :209-17.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
130107-AP 100 µL
MZF1 (Myeloid Zinc Finger 1, MZF-1, Zinc Finger and SCAN Domain-containing Protein 6, Zinc Finger Protein 42, MZF, ZNF42, ZSCAN6) (AP) discontinued
Sign In for Pricing
View Details 
MBS7020993-01 0.02 mg
Recombinant Bacillus anthracis Large-conductance mechanosensitive channel (mscL)
Sign In for Pricing
View Details MBS7020993-02 0.1 mg
Recombinant Bacillus anthracis Large-conductance mechanosensitive channel (mscL)
Sign In for Pricing
View Details MBS7020993-03 5x 0.1 mg
Recombinant Bacillus anthracis Large-conductance mechanosensitive channel (mscL)
Sign In for Pricing
View Details MBS1137147-01 0.02 mg (E-Coli)
Recombinant Yersinia enterocolitica Urease subunit beta (ureB)
Sign In for Pricing
View Details